Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-09-16
1990-05-22
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
549392, 549393, A61K 3135, C07D31186
Patent
active
049278495
ABSTRACT:
The xanthosulfonamido and benzensulfonamido derivatives corresponding to the formula: ##STR1## wherein x represents hydrogen, alkyl, alkoxy or halogen, Y represents an alkyl, alkoxy or halogen and Z represents the group ##STR2## or Y and Z taken together form the group: ##STR3## wherein R.sub.1 in turn is a group selected among electron attracting groups, halogens and the group: ##STR4## itself, possess activity in inhibiting the aldose-reductase enzyme system and are thus useful in the treatment of the complications, at the eye and peripheral neuropathy levels, as induced by diabetes.
REFERENCES:
patent: 3678077 (1972-07-01), Nakanishi et al.
patent: 3849565 (1974-11-01), Pfister et al.
Baldacci Massimo
Caccia Giulio
Chan Nicky
Laboratori Baldacci SpA
LandOfFree
Sulfonamido derivatives inhibiting the aldose reductase enzyme s does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sulfonamido derivatives inhibiting the aldose reductase enzyme s, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sulfonamido derivatives inhibiting the aldose reductase enzyme s will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2135198